PURCHASING SUPPLY CHAIN MANAGER

BlueRock Therapeutics a wholly-owned and independently operated subsidiary of Bayer AG is a leading engineered cell therapy company pioneering a new generation of cellular medicines. Utilizing our proprietary CELLGENE platform we direct cellular differentiation and genetically engineer cells to create transformative therapies for patients suffering from neurological and ophthalmological diseases.
...
Founded in 2016 BlueRock is at the forefront of the convergence of cell biology and genetic engineering. Our mission is to harness pluripotent stem cell technology and gene editing to deliver authentic functional cell therapies that address the root causes of disease and offer hope to millions of patients worldwide.
Our foundational science enables the generation and directed differentiation of universal pluripotent stem cells into authentic functional cells for allogeneic cellular therapies.
We are passionate about realizing the promise of cell and gene therapy shaping the future of regenerative medicine and delivering new therapies to patients with limited or no treatment options.
BlueRock Therapeutics a wholly owned and independently operated subsidiary of Bayer AG is a leading engineered cell therapy company using its unique cellgene platform to direct cellular differentiation and genetically engineer cells to create a new generation of cellular medicines that address large patient populations suffering from neurological cardiovascular and immunology diseases.
The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Founded in 2016 to capitalize on these technological breakthroughs we are advancing our novel cellgene platform to develop manufacture and deliver an entirely new generation of authentic and engineered cell therapies across two therapeutic areas: neurology and immunology.
Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells enabling them to produce enzymes antibodies and other proteins for additional therapeutic benefit.
The Director Supply Chain is responsible for leading BlueRock Therapeutics end-to-end supply chain strategy and operations in support of research process development clinical manufacturing and clinical trial execution. As a key member of the Cell Therapy Product Supply Operations organization this role ensures the reliable compliant and scalable supply of critical materials products and services required to advance BlueRocks clinical-stage cell therapy portfolio.
The Director will establish and lead integrated planning strategic sourcing procurement materials management inventory control and distribution capabilities across the organization. This individual will partner closely with Manufacturing Technical Operations MSAT Process Development Quality Regulatory Clinical Operations and external suppliers to mitigate supply risk improve operational performance and enable successful delivery of clinical programs.
This leader will oversee teams responsible for procurement planning and materials management while building the processes systems and organizational capabilities necessary to support the business.
Develop and lead an integrated supply planning process that aligns demand manufacturing capacity inventory and sourcing strategies with CMC development plans and clinical program requirements.
Implement supply chain standards metrics and governance to improve forecasting accuracy inventory performance and operational execution.
Lead capacity planning and scenario modeling activities to support program prioritization resource allocation and business decision-making.
Develop sourcing strategies for critical raw materials consumables testing services and outsourced manufacturing activities to ensure continuity of supply an

View the full posting and apply